Staphylococcus aureus nasal carriage among the diabetic and non-diabetic haemodialysis patients

Basit Öğe Kaydı
dc.contributor.authorDuran, N.
dc.contributor.authorOcak, S.
dc.contributor.authorEskiocak, A. F.
dc.date.accessioned2024-09-18T20:59:06Z
dc.date.available2024-09-18T20:59:06Z
dc.date.issued2006
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractStaphylococcus aureus is the most common cause of serious infections in patients undergoing long-term haemodialysis (HD). S. aureus infections in HD patients are associated with considerable morbidity and mortality. Especially, methicillin-resistant S. aureus (MRSA) strains are becoming increasingly multidrug-resistant and have recently developed resistance to vancomycin, used successfully to treat MRSA for more than 30 years. In vitro determination of resistance patterns of S. aureus is critical in terms of administering suitable antimicrobial treatment. The objective of this study was to identify the frequency of S. aureus among diabetic and non-diabetic HD patients and to investigate resistance patterns against various antibiotics used broadly for treatment. This study was carried out between January 2004 and December 2004. In the present survey, 261 patients undergoing HD treatment from three HD units in Hatay were examined. A total of 148 Staphy-lococcus aureus strains were processed to assess their occurrence rates and antimicrobial susceptibility profiles. S. aureus positivity was determined in 148 (56.7%) of the 261 HD patients and 26 (16.2%) of the 160 individuals in the control group. The difference was significant (p < 0.001). HD length was found to be 38.4 +/- 24.3 months in the patients of S. aureus carrier and 27.3 +/- 18.5 months in non-carrier patients. Significant correlation was also identified between durations those on HD and the isolation of S. aureus (p < 0.001). However, the carrier state was unrelated to the presence of diabetes mellitus (DM), age or sex. In conclusion, nasal carriage of S. aureus was found to be more prevalent in HD patients than that in those in the control group. Also, it is concluded that DM was not a risk factor for the nasal carriage of S. aureus. In addition, the rates of antibiotic resistance of S. aureus strains were found to be quite higher in HD patients than in the control group (p < 0.05).en_US
dc.identifier.doi10.1111/j.1742-1241.2005.00789.x
dc.identifier.endpage1209en_US
dc.identifier.issn1368-5031
dc.identifier.issn1742-1241
dc.identifier.issue10en_US
dc.identifier.pmid16981965en_US
dc.identifier.scopus2-s2.0-33748522669en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1204en_US
dc.identifier.urihttps://doi.org/10.1111/j.1742-1241.2005.00789.x
dc.identifier.urihttps://hdl.handle.net/20.500.12483/12369
dc.identifier.volume60en_US
dc.identifier.wosWOS:000240404300014en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofInternational Journal of Clinical Practiceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectStaphylococcus aureusen_US
dc.subjectnasal carriageen_US
dc.subjectMRSAen_US
dc.subjecthaemodialysisen_US
dc.subjectsusceptibilityen_US
dc.titleStaphylococcus aureus nasal carriage among the diabetic and non-diabetic haemodialysis patientsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
569.34 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu